The agenda for the Nov 2015
meeting of the Pharmaceutical
Benefits Advisory Committee has
been released, with more than 70
new and amended listings to be
considered, as well as reports from
the Drug Utilisation Sub Committee.
One of the submissions is for
an Unrestricted listing for GSK’s
Arnuity Ellipta (fluticasone furoate)
for the treatment of asthma.
Consumer comments on the
agenda close on 07 Oct - for details
see www.pbs.gov.au.The above article was sent to subscribers in Pharmacy Daily's issue from 27 Aug 15 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 27 Aug 15
THE role and significance of community pharmacy in regional areas was a key focus of discussion for the Nationals leader David Littleproud during last week’s visit to Orana Mall Pharmacy as part of a regional tour.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.